GSKGSK
13F holders, Q1 2026 (March 31)5holders
1new positions
1sold out
$55.19avg. 13F price*
At the end of Q1 2026, 5 institutions reported holding GSK PLC (GSK) in their 13F filings, unchanged from Q4 2025. 1 opened new positions and 1 sold out. The largest holders were Eads & Heald Wealth Management ($219K), Cascades Capital Asset Management, LLC ($104K) and Asset Planning,Inc ($15K).
- Company
- GSK PLC
- CUSIP
- 37733W105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $104K |
| Exits | 1 | $64K |
All 13F filers, Q4 2025 → Q1 2026: 1,888 shares bought and 1,620 shares sold, net +268 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Eads & Heald Wealth Management | 0.11% | Reduce -7.5% | 3,971 | $219K |
| Cascades Capital Asset Management, LLC | 0.04% | New | 1,888 | $104K |
| Asset Planning,Inc | 0.01% | No change | 264 | $15K |
| Byrne Asset Management LLC | 0.00% | No change | 56 | $3K |
| Huntington National Bank | 0.00% | No change | 1 | $40 |
"% of holder's portfolio" is GSK's weight in each manager's 13F, not the share of GSK PLC the manager owns.